• Glenn Hearson

Systematic review and meta-analysis of anakinra, sarilumab, siltuximab and tocilizumab for #COVID-19

A paper "Systematic review and meta-analysis of anakinra, sarilumab, siltuximab and tocilizumab for COVID-19" paper has just been published in BMJ Thorax.


The paper by lead authors Dr Fasihul Khan and Professor Gisli Jenkins searched electronic databases on 7 January 2021 to identify studies of immunomodulatory agents (anakinra, sarilumab, siltuximab and tocilizumab) for the treatment of #COVID-19. The primary outcomes were severity on an Ordinal Scale measured at day 15 from intervention and days to hospital discharge. Key secondary endpoints included overall mortality.


Click on the image below to view/download a PDF of the publication



4 views0 comments
  • Twitter

© 2020 by Nottingham Covid Research Group

Nottingham

England